Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-336-2 | CAS number: 157348-58-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2004-07-05 to 2004-07-21
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- 2001
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- 2,3-Epoxypropyl neodecanoate, oligomeric reaction products with phosphorous acid
- EC Number:
- 500-336-2
- EC Name:
- 2,3-Epoxypropyl neodecanoate, oligomeric reaction products with phosphorous acid
- Cas Number:
- 157348-58-8
- Molecular formula:
- Exact identification is not feasible
- IUPAC Name:
- Copolymer of neodecanoic acid oxiranylmethyl ester and phosphorous acid
- Test material form:
- liquid
- Details on test material:
- Copolymer of neodecanoic acid oxiranylmethyl ester and phosphorous acid, manufactured by Degussa GmbH, Batch: 413250
Constituent 1
- Specific details on test material used for the study:
- PREPARATION of the TEST ITEM
- In the first and second step 2000 mg of the test item were diluted in Cottonseed Oil (Sigma Chemicals Co., Lot 103K0064) ad 10 mL.
- The test substance was freshly mixed prior to administration and stirred troughout dose administration to guarantee stability and homogenicity.
The vehicle was chosen due to its non-toxic characteristics.
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Rats (HsdBrlHan: WIST), Sex: female
- Step 1: Body weight at the commencement of the study: 150 - 153 g
Step 2: Body weight at the commencement of the study: 140 - 165 g
- Three female animals were used for each step
- The animals were derived from a controlled full barrier maintained breeding system (SPF)
- Source: Harlan Winkelmann GmbH, D-33178 Borchen
- According to Art. 9.2, No.7 of the Greman Act on Animal Welfare the animals were bred for experimental purposes.
ANIMAL HUSBANDRY
The animals were barrier maintained (semi-barrier) in an air conditioned room
- Temperature: 22 +/- 3 °C
- Rel. humidity: 55 +/- 10%
- Artificial change: 10 x / hour
- Feeding ad libitum, Altromin 1324 maintenance diet for rats and mice, totally-pathogen-free (TPF)
- Free access to tap water (drinking water, municipal residue control, microbiol. controlled periodically)
- The animals were kept in Macrolon cages on Altromin saw fiber bedding
- Certificates of food, water and bedding are filed at BSL Bioservice
- Adequate acclimatization period
PREPARATION OF THE ANIMALS
- The animals were marked for individual identification by tail painting
- Prior to the adminstration a detailed clinical observation was made of all animals
- Prior to administration of the test item animals were fasted by withholding food overnight.
Following the period of fasting the animals were weighed and the test item was administered. Then the food was withheld for a further 3-4 hours.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- cotton seed oil
- Details on oral exposure:
- ADMINISTRATION:
- The test item was aministered in a single dose by gavage using an intubation cannula.
- Volume of administration: The test item was administered according to body weight at a volume of 10 mL/kg bw. - Doses:
- The starting dose (step 1 and 2) was selected to be 2000 mg/kg body weight. According to the acute toxic class method regime no further testing was required since no compound-related mortality was found.
- No. of animals per sex per dose:
- 6 (step 1 and 2)
- Control animals:
- no
- Details on study design:
- OBSERVATION:
- Animals were observed for 14 days after dosing.
WEIGHT ASSESSMENT:
- The animals were weighed prior to the administration and once a week thereafter.
CLINICAL EXAMINATION:
- A careful clinical examination was made several times on the day of dosing. Part of this were at least three observations within the first four hours post-dose.
Animals were observed once a day thereafter.
- Cageside observations included changes in the skin and fur, eyes and mucous membranes. Also respiratory, circulatory, autonomic and central nervous systems and somatomotor activity and behaviour pattern were examined. Particular attention was directed to observations of tremor, convulsions, salivation, diarrhoea, lethargy, sleep and coma.
PATHOLOGY:
- At the end of the observation period - Statistics:
- EVALUATION OF RESULTS:
Individual reactions of each animal were recorded at each observation time. Toxic response data were recorded by sex and dose level. Nature, severity and duration of clinical observations were described. Body weight changes were summarized in tabular form. Necropsy findings were described.
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths occured.
- Clinical signs:
- No clinical signs of toxicity were observed throughout the observation period for any animals of step 1 and 2.
- Body weight:
- Throughout the 14-days observation period no weight loss was recorded in any animals of step 1 and 2 (see tables "Absolute body weights in g" below).
The weight gain was within the expected range. - Gross pathology:
- Beside acute injection of blood vessels in the adominal region, which is due to the euthanasia injection no special gross pathological changes were found in any animals of step 1 nad 2.
- Other findings:
- No other treatment related effects were observed.
Any other information on results incl. tables
Absolute Body Weights in g
Step 1 (2000 mg/kg bw)
Animal No./Sex | Day 0 | Day 7 | Day 14 |
1 / female |
150 | 167 | 182 |
2 / female | 153 | 179 | 193 |
3 / female | 151 | 182 | 203 |
Step 2 (2000 mg/kg bw)
Animal No./Sex | Day 0 | Day 7 | Day 14 |
1 / female | 147 | 164 | 167 |
2 / female | 140 | 160 | 162 |
3 / female | 165 | 176 | 188 |
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of this study the acute toxicity after oral application is greater than 2000 mg/kg bw.
- Executive summary:
In this study the acute toxic class method according to OECD 423 was performed with the test item.
In the first step the test item was given at the limit dose of 2000 mg/kg body weight to a group of 3 female rats (HsdBrlHan:WIST) as a single administration by oral gavage at the volumne of 10 mL/kg bw. In the second step the test item was given at the same dose and volume to a further group of 3 female rats (HsdBrlHan:WIST).
The dosage of 2000 mg/kg bw caused no compound-related mortality in any animals of step 1 and 2 within 14 days post-dose.
A careful cinical examination was made several times on the day of dosing. Part of this were at least three observations within the first four hours post-dose. Animals were observed once a day thereafter.
At the end of the observation period the surviving animals were sacrified. Necropsy of all animals was carried out to record gross pathological changes.
No clinical signs of toxicity were observed throughout the observation period for any animals of step 1 and 2.
Beside acute injection of blood vessels in the abdominal region, which is due to the euthanasia injection no special gross pathological changes were found in any animals of step 1 and 2.
Throughout the 14 -days observation period no weight loss was recorded in any animals of step 1 and 2. The weight gain was within the expected range.
No other treatment related effects were observed.
Therefore, under the conditions of this study the acute toxicity after oral application is greater than 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.